首页 | 本学科首页   官方微博 | 高级检索  
     


Sustained Remissions with Long-term Weekly Chlorambucil Maintenance Therapy in Patients with Mucosa-Associated Lymphoid Tissue Lymphoma
Authors:Arumugam?Manoharan  author-information"  >  author-information__contact u-icon-before"  >  mailto:a.manoharan@unsw.edu.au"   title="  a.manoharan@unsw.edu.au"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author
Affiliation:Department of Clinical Haematology, St. George Hospital, University of New South Wales, Sydney, Australia. a.manoharan@unsw.edu.au
Abstract:Five patients with mucosa-associated lymphoid tissue (MALT) lymphoma (Helicobacter pylori negative) were initially treated with daily chlorambucil (Chl, 0.06-0.08 mg/kg per day) and achieved complete remission (n = 4) or partial remission (n = 1).They were then given long-term weekly Chl as maintenance therapy with good results. One patient came off treatment and has remained in continued remission for 44 months. This simple, low-cost, and convenient approach deserves further evaluation in patients with MALT lymphoma and other indolent and incurable lymphoproliferative disorders.
Keywords:MALT lymphoma  Weekly maintenance therapy
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号